Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...

Semaglutide prescription initiation predictors included female sex and use of antidepressants among patients with obesity without diabetes.

Semaglutide, the drug sold as Ozempic to treat type 2 diabetes and Wegovy for weight loss, reduced alcohol cravings and ...

We've all experienced it: you're in the middle of a conversation, searching for a word, a name, or a title, and… nothing. You know you know it—you can almost feel it—but it just won't come. This ...

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

I have tested several Saucony running shoes over the years, including multiple versions of the American brand’s popular ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Once opened, compounded semaglutide typically lasts 28 days in the fridge. Compounded semaglutide, which contains the same active ...

He was reading his tongue. For more stories about The Power of Personal Style, click or tap the play button above to hear the full episode of Under the Influence. Find more episodes on the CBC ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is primarily ...

Eli Lilly Stock: What Investors Should Watch in 2025 By Nathan Reiff - Jan 29, 2025 GLP-1 treatments such as semaglutide (under the brand names Ozempic and Wegovy) by Novo Nordisk (NYSE ...

Com­pound­ing fa­cil­i­ty ProRx Phar­ma­cy Net­work has re­ceived an FDA warn­ing let­ter over is­sues with its semaglu­tide and tirzepatide pro­duc­tion.

GLP-1 treatments such as semaglutide (under the brand names Ozempic and Wegovy) by Novo Nordisk A/S (NYSE: NVO) were likely the hottest medical sector story in 2024. With its offering of ...